[{"NetIncomeLoss_1_Q1_USD":-16007000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":3176000.0,"ContractWithCustomerAssetNetCurrent_0_Q1_USD":232000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":2.65,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-5000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":23500000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-20559000.0,"Depreciation_1_Q1_USD":75000.0,"PurchaseObligation_0_Q1_USD":26800000.0,"PaymentsToAcquireInvestments_1_Q1_USD":19944000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":1163000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":9000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":5000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":1641000.0,"AssetsCurrent_0_Q1_USD":175420000.0,"RestructuringCharges_1_Q1_USD":0.0,"DilutiveSecurities_1_Q1_USD":0.0,"ContractWithCustomerLiability_0_Q1_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7457452.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":231000.0,"NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_1_Q1_USD":303000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1585000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-5000.0,"CommonStockSharesIssued_0_Q1_shares":117963912.0,"Assets_0_Q1_USD":205866000.0,"ShareBasedCompensation_1_Q1_USD":1251000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":6350000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":8246279.0,"CommitmentsAndContingencies_0_Q1_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":1732000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":115422628.0,"GeneralAndAdministrativeExpense_1_Q1_USD":5944000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1887000.0,"ClassOfWarrantOrRightOutstanding_0_Q1_shares":414252.0,"ResearchAndDevelopmentExpense_1_Q1_USD":10073000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":3.28,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":8026000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":5452000.0,"InvestmentsAndCash_0_Q1_USD":177255000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":1731000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-5000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-2185000.0,"AccountsReceivableNetCurrent_0_Q1_USD":700000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":38000.0,"CommonStockValue_0_Q1_USD":12000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-1000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":67592000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-16012000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":2281000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":433000.0,"OtherAssetsNoncurrent_0_Q1_USD":369000.0,"ShortTermLeaseCommitmentAmount_0_Q1_USD":0.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":4628000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":341116000.0,"Liabilities_0_Q1_USD":29631000.0,"Dividends_1_Q1_USD":0.0,"OperatingLeaseLiability_0_Q1_USD":6634000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"DepreciationAndAmortization_1_Q1_USD":996000.0,"RevenueRemainingPerformanceObligation_0_Q1_USD":0.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":1392000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":1112000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":1731000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":3007780.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":1732000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":648000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1_Q1_shares":4139.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":5.17,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1251000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-16592000.0,"ProceedsFromWarrantExercises_1_Q1_USD":1649000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":1801000.0,"LiabilitiesCurrent_0_Q1_USD":11642000.0,"AccountsPayableCurrent_0_Q1_USD":4638000.0,"CommonStockSharesOutstanding_0_Q1_shares":117963912.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":157311000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":231000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":337000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":14928000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0992,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q1_USD":11300000.0,"SubleaseIncome_1_Q1_USD":36000.0,"ShortTermLeaseCost_1_Q1_USD":60000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":207730.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":14928000.0,"NumberOfOperatingSegments_1_Q1_pure":1.0,"OperatingLeasePayments_1_Q1_USD":934000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2245000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4024000.0,"ShortTermInvestments_0_Q1_USD":13385000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":366000.0,"LeaseCost_1_Q1_USD":979000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2694000.0,"CommonStockSharesAuthorized_0_Q1_shares":150000000.0,"OperatingIncomeLoss_1_Q1_USD":-15511000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q1_shares":67863.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-15969000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":1100000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":6.27,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":20380000.0,"PreferredStockValue_0_Q1_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":1.11,"OperatingLeaseCost_1_Q1_USD":662000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":205866000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1044000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":30441000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2006000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":1299000.0,"OperatingExpenses_1_Q1_USD":16017000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.14,"OtherLiabilitiesNoncurrent_0_Q1_USD":122000.0,"StockholdersEquity_0_Q1_USD":176235000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":615000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":0.0,"LongTermInvestments_0_Q1_USD":6554000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":506000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":7764164.0,"VariableLeaseCost_1_Q1_USD":293000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-164888000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":2893000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":906000.0,"Ticker":"VXRT","CIK":"72444","name":"VAXART, INC.","OfficialName":"Vaxart Inc Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"564888665.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]